ArticleFrontiers in network physiology2025
Towards standardizing mitral transcatheter edge-to-edge repair with deep-learning algorithm: a comprehensive multi-model strategy.
Article in Frontiers in network physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Severe mitral valve regurgitation requires comprehensive evaluation for optimal treatment. Initial screening uses transthoracic echocardiography (TTE), followed by transesophageal echocardiography (TEE) to determine eligibility for adequate intervention. Mitral Transcatheter Edge-to-Edge Repair (M-TEER) indications are based on detailed and quality valve and sub-valvular apparatus assessment, including anatomy and regurgitation pathophysiology. Aim: To develop AI algorithms for standardizing M-TEER eligibility assessment using TTE and TEE echocardiograms, supporting all stages of mitral valve regurgitation evaluation to assist non-expert centers throughout the entire process, from severe mitral valve regurgitation diagnostic to M-TEER procedure. Methods: Three deep learning algorithms were developed using echocardiographic data from M-TEER patients performed at Montreal Heart Institute (2018-2025). 1. ECHO-PREP was trained to identify key diagnostic views in TTE (n = 530) and diagnostic and procedural views in TEE (n = 2,222) examinations to determine the level of quality images needed to do a M-TEER. 2. 4D TEE segmentation with automated mitral valve area (MVA) quantification (n = 221), and 3. 2D TEE scallop-level segmentation of leaflets and sub-valvular structures (n = 992). Results: Preliminary results on test sets showed 95.7% accuracy in TTE view classification and 91% accuracy for TEE view classification. The 4D segmentation module demonstrated excellent agreement with manual MVA measurements (R = 0.84, p < 0.001), successfully discriminating patients undergoing M-TEER from those referred for surgical replacement (p = 0.046 for AI predictions). The 2D scallop-level analysis achieved a mean Dice score of 0.534 across 11 anatomical structures, with better performance in commonly represented configurations (e.g., A2-P2, P1-A2-P3). Conclusion: ECHO-PREP demonstrates the feasibility of an integrated AI-assisted workflow for MR assessment, combining quality control, dynamic 4D valve quantification, and scallop-level anatomy interpretation. These results support the potential of AI to standardize M-TEER eligibility, reduce inter-observer variability, and provide decision support across centers with different levels of expertise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.